Long COVID Trial, Recruiting NCT07726082 Sponsor: University Hospital, Basel, Switzerland Condition: Long COVID
Back to Long Covid

Long COVID Trial, Recruiting

NCT07726082
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been experiencing ongoing fatigue that has a significant effect on their daily life, based on a specific fatigue measurement scale (Chalder Fatigue Scale bimodal score of 4 or higher)

Who may not be able to join:

  • People who do not have sufficient proficiency in German to complete the study questionnaires
  • People who do not have the cognitive ability to understand the study procedures, for example due to dementia
  • People with serious medical conditions that could interfere with taking part, such as advanced organ failure, uncontrolled inflammatory or autoimmune diseases, or severe psychiatric disorders
  • People who currently have cancer or are receiving cancer treatment
  • People who are assessed by the trial team as not being suited to participating in a group setting — this may include situations where someone needs a level of individual support beyond what a group can offer, is unwilling to participate in group-based therapy, has personality traits the team considers incompatible with group dynamics, does not attend the required preparatory webinar, or where the therapeutic team identifies other significant reasons

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Katrin Bopp, Dr., University Hospital, Basel, Switzerland

Phone: +41 61 265 50 05

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Basel, Switzerland
Registry
ClinicalTrials.gov
Start date
1 August 2026
Est. completion
1 August 2027

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Retention rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov